http://purl.org/np/RA0FHkROmDX11eRGOg2zWiFGhL_kXfzSKr9iuXZOzZ1Os#Head
http://purl.org/np/RA0FHkROmDX11eRGOg2zWiFGhL_kXfzSKr9iuXZOzZ1Os
http://www.nanopub.org/nschema#hasAssertion
http://purl.org/np/RA0FHkROmDX11eRGOg2zWiFGhL_kXfzSKr9iuXZOzZ1Os#assertion
http://purl.org/np/RA0FHkROmDX11eRGOg2zWiFGhL_kXfzSKr9iuXZOzZ1Os
http://www.nanopub.org/nschema#hasProvenance
http://purl.org/np/RA0FHkROmDX11eRGOg2zWiFGhL_kXfzSKr9iuXZOzZ1Os#provenance
http://purl.org/np/RA0FHkROmDX11eRGOg2zWiFGhL_kXfzSKr9iuXZOzZ1Os
http://www.nanopub.org/nschema#hasPublicationInfo
http://purl.org/np/RA0FHkROmDX11eRGOg2zWiFGhL_kXfzSKr9iuXZOzZ1Os#pubInfo
http://purl.org/np/RA0FHkROmDX11eRGOg2zWiFGhL_kXfzSKr9iuXZOzZ1Os
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.nanopub.org/nschema#Nanopublication
http://purl.org/np/RA0FHkROmDX11eRGOg2zWiFGhL_kXfzSKr9iuXZOzZ1Os#assertion
http://purl.org/np/RA0FHkROmDX11eRGOg2zWiFGhL_kXfzSKr9iuXZOzZ1Os#assertion
http://www.w3.org/ns/prov#wasGeneratedBy
S&T TWOC project version 1
http://purl.org/np/RA0FHkROmDX11eRGOg2zWiFGhL_kXfzSKr9iuXZOzZ1Os#version
http://www.w3.org/ns/prov#value
1
http://www.w3.org/1999/02/22-rdf-syntax-ns#object
https://uts.nlm.nih.gov/uts/umls/concept/C0442886
secondary infections
http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate
http://twoc-nlp-database-server-1:8555/solr/predicates/select?q=TRIPLE_UID:kmvq6bit-TRIPLE-ABSTRACT-9
experience
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://uts.nlm.nih.gov/uts/umls/concept/C0011777
dexamethasone
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://uts.nlm.nih.gov/uts/umls/concept/C0030705
patients
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://uts.nlm.nih.gov/uts/umls/concept/C0441833
group
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://uts.nlm.nih.gov/uts/umls/concept/C0687744
group
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://uts.nlm.nih.gov/uts/umls/concept/C1257890
group
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://uts.nlm.nih.gov/uts/umls/concept/C1442989
standard
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://uts.nlm.nih.gov/uts/umls/concept/C1548173
standard
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://uts.nlm.nih.gov/uts/umls/concept/C1561557
group
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://uts.nlm.nih.gov/uts/umls/concept/C1705428
group
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://uts.nlm.nih.gov/uts/umls/concept/C1705429
group
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://uts.nlm.nih.gov/uts/umls/concept/C1947933
care
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://uts.nlm.nih.gov/uts/umls/concept/C2362566
care
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://uts.nlm.nih.gov/uts/umls/concept/C2828392
standard
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://uts.nlm.nih.gov/uts/umls/concept/C3272550
standard
http://www.w3.org/2000/01/rdf-schema#Triple-UID
http://twoc-nlp-database-server-1:8555/solr/triples/select?q=TRIPLE_UID:kmvq6bit-TRIPLE-ABSTRACT-9
kmvq6bit-TRIPLE-ABSTRACT-9
http://www.w3.org/2000/01/rdf-schema#sentence
http://www.w3.org/2000/01/rdf-schema#label
Thirty-three patients (21.9%) in the dexamethasone group vs 43 (29.1%) in the standard care group experienced secondary infections, 47 (31.1%) vs 42 (28.3%) needed insulin for glucose control, and 5 (3.3%) vs 9 (6.1%) experienced other serious adverse events.
http://www.w3.org/2000/01/rdf-schema#triple
http://www.w3.org/2000/01/rdf-schema#label
Thirty - three patients ( 21.9 % ) in the dexamethasone group vs 43 ( 29.1 % ) in the standard care group experienced secondary infections
http://purl.org/np/RA0FHkROmDX11eRGOg2zWiFGhL_kXfzSKr9iuXZOzZ1Os#provenance
http://purl.org/np/RA0FHkROmDX11eRGOg2zWiFGhL_kXfzSKr9iuXZOzZ1Os#assertion
http://www.w3.org/ns/prov#generatedAtTime
2021-07-25T21:45:49.773306
http://purl.org/np/RA0FHkROmDX11eRGOg2zWiFGhL_kXfzSKr9iuXZOzZ1Os#pubInfo
http://purl.org/np/RA0FHkROmDX11eRGOg2zWiFGhL_kXfzSKr9iuXZOzZ1Os#sig
http://purl.org/nanopub/x/hasAlgorithm
RSA
http://purl.org/np/RA0FHkROmDX11eRGOg2zWiFGhL_kXfzSKr9iuXZOzZ1Os#sig
http://purl.org/nanopub/x/hasPublicKey
MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCSLeezU8JYlBsrgXOGXX4fxOq4oydsMzMK1CN0Rez2OEd2IYk18R4DetcZXwGhN3Pil7qcgNkiGvTirJXIo8zHl7jVehs19EdYtrttCKEaXRzWIr4LuCrfGedkvonEMWqR8e1GdQsLgEEyM50BD6Qw+srQt9ozcqf/9wG2MAMX9QIDAQAB
http://purl.org/np/RA0FHkROmDX11eRGOg2zWiFGhL_kXfzSKr9iuXZOzZ1Os#sig
http://purl.org/nanopub/x/hasSignature
RnTbRncETO8rcPKb0HBPakUVuL0neiEyHGUfEMJ2fykJhGvgukg7SaLYPwNHr3ConoWrBe5EB0wnwNIUY3+KZnVW08+HZdMQT4z48kt1g7KgCezstbdeIyPKN81e+gjPkyWJiKVd3OE0asrdZkUoSILfJHaK1ZQwner7tWg7/ZY=
http://purl.org/np/RA0FHkROmDX11eRGOg2zWiFGhL_kXfzSKr9iuXZOzZ1Os#sig
http://purl.org/nanopub/x/hasSignatureTarget
http://purl.org/np/RA0FHkROmDX11eRGOg2zWiFGhL_kXfzSKr9iuXZOzZ1Os
http://purl.org/np/RA0FHkROmDX11eRGOg2zWiFGhL_kXfzSKr9iuXZOzZ1Os
http://www.w3.org/ns/prov#generatedAtTime
2021-07-25T21:45:49.773306
http://purl.org/np/RA0FHkROmDX11eRGOg2zWiFGhL_kXfzSKr9iuXZOzZ1Os
http://www.w3.org/ns/prov#wasAttributedTo
https://orcid.org/0000-0002-8954-0470